Paramedic Administered Sodium Nitrite Ineffective for Cardiac Arrest. Detroit Fire Department paramedics ambulance. Staff photo by Dave Fornell. #ACC20 #ACC2020
News | Sudden Cardiac Arrest | April 02, 2020

April 2, 2020 — Among patients who had an out-of-hospital cardiac arrest, intravenous sodium nitrite given by...

News | Renal Denervation | April 01, 2020

April 1, 2020 — Three months after undergoing renal denervation (RDN), patients with untreated high blood pressure...

News | Renal Denervation | April 01, 2020

April 1, 2020 — Three months after undergoing renal denervation (RDN), patients with untreated high blood pressure...

The chat box in a the minutes prior to the beginning of the opening session of the ACC 2020 virtual meeting. Hundreds of clinicians said hello from their locations around the globe, keeping with the ACC  messaging on the screen. #ACC20 #ACC #ACC2020

The chat box in the minutes prior to the beginning of the ACC 2020 virtual meeting's opening session. Hundreds of clinicians said hello from their locations around the globe, keeping with the ACC messaging on the screen.

Blog | ACC | April 01, 2020
Videos | Structural Heart | April 01, 2020

A review of the PARTNER 3 Low-Risk Trial with ...

While the HRS annual meeting is cancelled, the society has created a resource page to help its members in the fight against COVID-19 at https://www.hrsonline.org/COVID19-Challenges-Solutions. #HRS #COVID19 #coronavirus #SARScov2

While the HRS annual meeting is cancelled, the society has created a resource page to help its members in the fight against COVID-19 at https://www.hrsonline.org/COVID19-Challenges-Solutions

Feature | Coronavirus (COVID-19) | April 01, 2020 | Dave Fornell, Editor

April 1, 2020 — Due to the continued global escalation of the novel coronavirus (COVID-19, SARS-CoV-2), the Heart...

William O’Neill, M.D., Henry Ford Hospital, speaking at the announcement of the creation of the Cardiogenic Shock Initiative in 2016. O'Neill asked the same partner hospitals in the Detroit area to pool resources to create a COVID-19 study group to help speed the gathering of data in COVID-19 drug trials.

William O’Neill, M.D., Henry Ford Hospital, speaking at the announcement of the creation of the Cardiogenic Shock Initiative in 2016. O'Neill asked the same partner hospitals in the Detroit area to pool resources to create a COVID-19 study group to help speed the gathering of data in COVID-19 drug trials.

News | Coronavirus (COVID-19) | March 31, 2020

March 31, 2020 — Four metropolitan Detroit hospital systems and a leading research university announced a...

News | March 30, 2020

March 30, 2020 — Smokers who received smoking cessation counseling and used electronic cigarettes (e-cigarettes)...

Closing access to the radial artery after harvesting a section of the artery for a coronary artery bypass graft (CABG). Photo by Getty Images. #ACC20 #ACC2020

Closing access to the radial artery after harvesting a section of the artery for a coronary artery bypass graft (CABG). Photo by Getty Images.

News | Cardiovascular Surgery | March 30, 2020

March 30, 2020 — Patients undergoing coronary bypass graft (CAGB) surgery lived longer and had better outcomes when...

The Edwards Lifesciences Cardioband for tricuspid valve regurgitation. #COVID19 #coronavirus

The Edwards Lifesciences Cardioband for tricuspid valve regurgitation is one of the device trials being paused for the duration of the COVID-19 outbreak.

News | Heart Valve Technology | March 30, 2020

March 30, 2020 — Edwards Lifesciences Corp. announced it is temporarily pausing new enrollments in its active...

AHA, ACC, HRS, SCAI and other medical societies call for federal government to do what is needed to get medical supplies to front-line clinicians fighting COVID-19. #COVID19 #SARScov2 #Coronavirus
News | Coronavirus (COVID-19) | March 30, 2020

March 30, 2020 — A group of 13 U.S. medical societies sent an open letter to Congress appealing to them to do what...

Conclusions from the TAVR vs surgery trial for aortic valve replacement in the U.K. presented by William D. Toff, M.D. at ACC 20. #ACC20 #ACC2020 #TAVR #TAVR

Conclusions from the real world TAVR vs. surgery trial for aortic valve replacement outcomes in the U.K., presented by William D. Toff, M.D. at ACC 20. 

News | Heart Valve Technology | March 30, 2020

March 30, 2020 — Patients in the United Kingdom (U.K.) who underwent transcatheter aortic valve replacement (TAVR)...

PARTNER 3 trial shows positive results for Sapien 3 in low-risk surgical patients. #ACC20 #ACC2020 #Sapien3 #TAVR
Feature | Heart Valve Technology | March 30, 2020

March 30, 2020 — Patients undergoing transcatheter aortic valve repair (TAVR) low-risk patients at two years did...

News | Heart Valve Technology | March 29, 2020

March 29, 2020 — Worse than expected outcomes were found for survival and quality of life among patients undergoing...

Patients with worsening heart failure and reduced ejection fraction who received the investigational drug vericiguat had a significantly lower rate of cardiovascular death or heart failure hospitalization compared with those receiving a placebo, based on research presented at the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC) #ACC20/#WCCardio
News | Heart Failure | March 29, 2020

March 29, 2020 — Patients with worsening heart failure and reduced ejection fraction who received the...

Overlay Init